Ujjwal M Mahajan
Overview
Explore the profile of Ujjwal M Mahajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sirtl S, Hohmann E, Ahmad M, Bretthauer K, Junge M, Vornhulz M, et al.
Pancreatology
. 2024 Aug;
24(6):840-846.
PMID: 39147660
Background: With respect to severity and outcome of an index episode of idiopathic acute pancreatitis the current literature reports conflicting retrospective results. One reason might be the retrospective study design...
2.
Sirtl S, Bretthauer K, Ahmad M, Hohmann E, Schmidt V, Allawadhi P, et al.
Pancreas
. 2024 May;
53(8):e633-e640.
PMID: 38696426
Background/aim: Severity of microlithiasis- and sludge-induced pancreatitis in comparison to gallstone-induced pancreatitis has never been studied for a lack of definition. Materials And Methods: In this retrospective cohort study, 263...
3.
Benitz S, Steep A, Nasser M, Preall J, Mahajan U, McQuithey H, et al.
bioRxiv
. 2024 Jan;
PMID: 38168289
Cellular plasticity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) starting from the conversion of normal cells into precancerous lesions to the progression of carcinoma subtypes associated with aggressiveness and...
4.
Ye L, Ziesch A, Schneider J, Ofner A, Niess H, Denk G, et al.
Aging Dis
. 2023 Jun;
15(1):338-356.
PMID: 37307826
Primary sclerosing cholangitis (PSC) represents a chronic liver disease characterized by poor prognosis and lacking causal treatment options. Yes-associated protein (YAP) functions as a critical mediator of fibrogenesis; however, its...
5.
Mahajan U, Oehrle B, Sirtl S, Alnatsha A, Goni E, Regel I, et al.
Gastroenterology
. 2022 Jul;
163(5):1407-1422.
PMID: 35870514
Background & Aims: Pancreatic ductal adenocarcinoma cancer (PDAC) is a highly lethal malignancy requiring efficient detection when the primary tumor is still resectable. We previously developed the MxPancreasScore comprising 9...
6.
Sirtl S, Mahajan U, Auernhammer C, Dziadkiewicz P, Hohmann E, Wojcik M, et al.
Pancreatology
. 2022 May;
22(5):644-650.
PMID: 35589512
Background: Current guidelines provide weak recommendations to treat small (<2 cm) non-functional pancreatic neuroendocrine tumors with low Ki-67 proliferation index either by resection or clinical follow-up. However, there is a...
7.
Orben F, Lankes K, Schneeweis C, Hassan Z, Jakubowsky H, Krauss L, et al.
JCI Insight
. 2022 Apr;
7(10).
PMID: 35439169
Systemic therapies for pancreatic ductal adenocarcinoma (PDAC) remain unsatisfactory. Clinical prognosis is particularly poor for tumor subtypes with activating aberrations in the MYC pathway, creating an urgent need for novel...
8.
Allawadhi P, Beyer G, Mahajan U, Mayerle J
Gastroenterology
. 2021 Sep;
161(6):1802-1805.
PMID: 34587487
No abstract available.
9.
Mahajan U, Li Q, Alnatsha A, Maas J, Orth M, Maier S, et al.
Gastroenterology
. 2021 Jun;
161(3):996-1010.e1.
PMID: 34097885
Backgrounds & Aims: Fluoropyrimidine c (5-fluorouracil [5FU]) increasingly represents the chemotherapeutic backbone for neoadjuvant, adjuvant, and palliative treatment of pancreatic ductal adenocarcinoma (PDAC). Even in combination with other agents, 5FU...
10.
Trapp S, Aghdassi A, Glaubitz J, Sendler M, Weiss F, Kuhn J, et al.
J Cell Mol Med
. 2021 Mar;
25(10):4658-4670.
PMID: 33682322
Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas patients with CF usually develop complete exocrine...